Evidence map›Paper›PMID 36137647›Full record

ArticleBJGP open2022

Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol.

Eva Hernandez-Garcia, Evangelia Chrysikou, Larissa Nekhlyudov, Derek W Gilroy, José M Ordóñez-Mena

Open access · goldAbstract read
In one paragraph

Article in BJGP open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Eva Hernandez-GarciaThe Bartlett School of Sustainable Construction, University College London, London, UK eva.hernandez.20@ucl.ac.uk.ORCID https://orcid.org/0000-0003-4492-2747
Evangelia ChrysikouThe Bartlett School of Sustainable Construction, University College London, London, UK.ORCID https://orcid.org/0000-0002-7894-6053
Larissa NekhlyudovDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0001-6747-4209
Derek W GilroyCentre for Clinical Pharmacology and Therapeutics, Division of Medicine, University College London, London, UK.ORCID https://orcid.org/0000-0003-3476-0844
José M Ordóñez-MenaNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-8965-104X
Brigham and Women's Hospital · USThe London College · GBTherapeutics Clinical Research · USUniversity of Crete · GRUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammation control is a fundamental part of chronic care in patients with a history of cancer and comorbidity. As the risk-benefit profile of anti-inflammatory drugs is unclear in survivors of cancer, GPs and patients could benefit from alternative non-pharmacological treatment options for dysregulated inflammation. There is a potential for home-built environment (H-BE) interventions to modulate inflammation; however, discrepancies exist between studies.

aimTo evaluate the effectiveness of H-BE interventions on cancer-associated inflammation biomarkers. DESIGN &

settingA systematic review and meta-analysis of randomised and non-randomised trials in community-dwelling adults.

methodPubMed and MEDLINE, Embase, Web of Science, and Google Scholar will be searched for clinical trials published in January 2000 onwards. The study will include H-BE interventions modifying air quality, thermal comfort, non-ionising radiation, noise, nature, and water. No restrictions to study population will be applied to allow deriving expectations for effects of the interventions in cancer survivors from available source populations. Outcome measures will be inflammatory biomarkers clinically and physiologically relevant to cancer. The first reviewer will independently screen articles together with GPs and extract data that will be verified by a second reviewer. The quality of studies will be assessed using the Cochrane risk-of-bias tools. Depending on the clinical and methodological homogeneity of populations, interventions, and outcomes, a meta-analysis will be conducted using random-effects models.

conclusionFindings will determine the effectiveness of H-BE interventions on inflammatory parameters, guide future directions for its provision in community-dwelling survivors of cancer and support GPs with safer anti-inflammatory treatment options in high-risk patients for clinical complications.

Indexed as

biomarkerscancer survivorchronic diseasecommunity carecomorbiditygeneral practicehome-built environmenthousinginflammation

Identifiers

PMID36137647
PMCPMC9904785
OpenAlexW4296683572

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.